Loading…

Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels

Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid) A receptor channels (α 1β 2γ 2-subunits) and glycine receptor channels (α 1β-subunits) transiently expressed in HEK293 cells. For electrophys...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pharmacology 2001-03, Vol.415 (2), p.135-140
Main Authors: Mohammadi, Bahram, Krampfl, Klaus, Moschref, Hafis, Dengler, Reinhard, Bufler, Johannes
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 140
container_issue 2
container_start_page 135
container_title European journal of pharmacology
container_volume 415
creator Mohammadi, Bahram
Krampfl, Klaus
Moschref, Hafis
Dengler, Reinhard
Bufler, Johannes
description Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid) A receptor channels (α 1β 2γ 2-subunits) and glycine receptor channels (α 1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α 1β 2γ 2 GABA A receptor channels or α 1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.
doi_str_mv 10.1016/S0014-2999(01)00847-0
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_77006104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299901008470</els_id><sourcerecordid>77006104</sourcerecordid><originalsourceid>FETCH-LOGICAL-e195t-62bb1a891a9352019cea9858947923caabdaa8b8bd745f61f29cb404388911b93</originalsourceid><addsrcrecordid>eNo9kE1PwkAQhjdGI4j-BM2ejB6qM_2g3ZOpRJGExIN68bLZbgdYU7a43WLw11sQPU0yed7JOw9j5wg3CDi8fQHAOAiFEFeA1wBZnAZwwPqYpSKAFMND1v9HeuykaT4AIBFhcsx6iGEaC4F99j6xnpzS3tSW1zPuF8Qtta5eudpTt14TL107585U7XddEf8yfsHH-X3Oc65syefVRhtL3JGmla8d1wtlLVXNKTuaqaqhs_0csLfHh9fRUzB9Hk9G-TQgFIkPhmFRoMoEKhElIaDQpESWZCJORRhppYpSqazIijKNk9kQZ6HQRQxxlHUZLEQ0YJe_d7vKny01Xi5No6mqlKW6bWSaAgyxCwzYxR5siyWVcuXMUrmN_LPRAXe_QNee1oacbLQhq6k03XdelrWRCHLrX-78y61cCSh3_iVEP9EydnY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77006104</pqid></control><display><type>article</type><title>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Mohammadi, Bahram ; Krampfl, Klaus ; Moschref, Hafis ; Dengler, Reinhard ; Bufler, Johannes</creator><creatorcontrib>Mohammadi, Bahram ; Krampfl, Klaus ; Moschref, Hafis ; Dengler, Reinhard ; Bufler, Johannes</creatorcontrib><description>Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid) A receptor channels (α 1β 2γ 2-subunits) and glycine receptor channels (α 1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α 1β 2γ 2 GABA A receptor channels or α 1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(01)00847-0</identifier><identifier>PMID: 11274991</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Cell Line ; Dose-Response Relationship, Drug ; GABA A receptor channel ; gamma-Aminobutyric Acid - pharmacology ; Glycine - pharmacology ; Glycine receptor channel ; Humans ; Kidney - cytology ; Neuroprotective Agents - pharmacology ; Patch-Clamp Techniques ; Patch–clamp technique ; Rapid application ; Receptors, GABA-A - drug effects ; Receptors, GABA-A - physiology ; Receptors, Glycine - drug effects ; Receptors, Glycine - physiology ; recombinant α 1β ; recombinant α 1β 2γ 2 ; Riluzole ; Riluzole - pharmacology</subject><ispartof>European journal of pharmacology, 2001-03, Vol.415 (2), p.135-140</ispartof><rights>2001 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11274991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohammadi, Bahram</creatorcontrib><creatorcontrib>Krampfl, Klaus</creatorcontrib><creatorcontrib>Moschref, Hafis</creatorcontrib><creatorcontrib>Dengler, Reinhard</creatorcontrib><creatorcontrib>Bufler, Johannes</creatorcontrib><title>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid) A receptor channels (α 1β 2γ 2-subunits) and glycine receptor channels (α 1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α 1β 2γ 2 GABA A receptor channels or α 1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.</description><subject>Cell Line</subject><subject>Dose-Response Relationship, Drug</subject><subject>GABA A receptor channel</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Glycine - pharmacology</subject><subject>Glycine receptor channel</subject><subject>Humans</subject><subject>Kidney - cytology</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Patch-Clamp Techniques</subject><subject>Patch–clamp technique</subject><subject>Rapid application</subject><subject>Receptors, GABA-A - drug effects</subject><subject>Receptors, GABA-A - physiology</subject><subject>Receptors, Glycine - drug effects</subject><subject>Receptors, Glycine - physiology</subject><subject>recombinant α 1β</subject><subject>recombinant α 1β 2γ 2</subject><subject>Riluzole</subject><subject>Riluzole - pharmacology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNo9kE1PwkAQhjdGI4j-BM2ejB6qM_2g3ZOpRJGExIN68bLZbgdYU7a43WLw11sQPU0yed7JOw9j5wg3CDi8fQHAOAiFEFeA1wBZnAZwwPqYpSKAFMND1v9HeuykaT4AIBFhcsx6iGEaC4F99j6xnpzS3tSW1zPuF8Qtta5eudpTt14TL107585U7XddEf8yfsHH-X3Oc65syefVRhtL3JGmla8d1wtlLVXNKTuaqaqhs_0csLfHh9fRUzB9Hk9G-TQgFIkPhmFRoMoEKhElIaDQpESWZCJORRhppYpSqazIijKNk9kQZ6HQRQxxlHUZLEQ0YJe_d7vKny01Xi5No6mqlKW6bWSaAgyxCwzYxR5siyWVcuXMUrmN_LPRAXe_QNee1oacbLQhq6k03XdelrWRCHLrX-78y61cCSh3_iVEP9EydnY</recordid><startdate>200103</startdate><enddate>200103</enddate><creator>Mohammadi, Bahram</creator><creator>Krampfl, Klaus</creator><creator>Moschref, Hafis</creator><creator>Dengler, Reinhard</creator><creator>Bufler, Johannes</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200103</creationdate><title>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</title><author>Mohammadi, Bahram ; Krampfl, Klaus ; Moschref, Hafis ; Dengler, Reinhard ; Bufler, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e195t-62bb1a891a9352019cea9858947923caabdaa8b8bd745f61f29cb404388911b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Cell Line</topic><topic>Dose-Response Relationship, Drug</topic><topic>GABA A receptor channel</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Glycine - pharmacology</topic><topic>Glycine receptor channel</topic><topic>Humans</topic><topic>Kidney - cytology</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Patch-Clamp Techniques</topic><topic>Patch–clamp technique</topic><topic>Rapid application</topic><topic>Receptors, GABA-A - drug effects</topic><topic>Receptors, GABA-A - physiology</topic><topic>Receptors, Glycine - drug effects</topic><topic>Receptors, Glycine - physiology</topic><topic>recombinant α 1β</topic><topic>recombinant α 1β 2γ 2</topic><topic>Riluzole</topic><topic>Riluzole - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohammadi, Bahram</creatorcontrib><creatorcontrib>Krampfl, Klaus</creatorcontrib><creatorcontrib>Moschref, Hafis</creatorcontrib><creatorcontrib>Dengler, Reinhard</creatorcontrib><creatorcontrib>Bufler, Johannes</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohammadi, Bahram</au><au>Krampfl, Klaus</au><au>Moschref, Hafis</au><au>Dengler, Reinhard</au><au>Bufler, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2001-03</date><risdate>2001</risdate><volume>415</volume><issue>2</issue><spage>135</spage><epage>140</epage><pages>135-140</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid) A receptor channels (α 1β 2γ 2-subunits) and glycine receptor channels (α 1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α 1β 2γ 2 GABA A receptor channels or α 1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>11274991</pmid><doi>10.1016/S0014-2999(01)00847-0</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-2999
ispartof European journal of pharmacology, 2001-03, Vol.415 (2), p.135-140
issn 0014-2999
1879-0712
language eng
recordid cdi_proquest_miscellaneous_77006104
source ScienceDirect Freedom Collection 2022-2024
subjects Cell Line
Dose-Response Relationship, Drug
GABA A receptor channel
gamma-Aminobutyric Acid - pharmacology
Glycine - pharmacology
Glycine receptor channel
Humans
Kidney - cytology
Neuroprotective Agents - pharmacology
Patch-Clamp Techniques
Patch–clamp technique
Rapid application
Receptors, GABA-A - drug effects
Receptors, GABA-A - physiology
Receptors, Glycine - drug effects
Receptors, Glycine - physiology
recombinant α 1β
recombinant α 1β 2γ 2
Riluzole
Riluzole - pharmacology
title Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20of%20the%20neuroprotective%20drug%20riluzole%20with%20GABA%20A%20and%20glycine%20receptor%20channels&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Mohammadi,%20Bahram&rft.date=2001-03&rft.volume=415&rft.issue=2&rft.spage=135&rft.epage=140&rft.pages=135-140&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/S0014-2999(01)00847-0&rft_dat=%3Cproquest_pubme%3E77006104%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e195t-62bb1a891a9352019cea9858947923caabdaa8b8bd745f61f29cb404388911b93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77006104&rft_id=info:pmid/11274991&rfr_iscdi=true